Conformational Dynamics of Threonine 195 and the S1 Subsite in Functional Trypsin Variants

Overview

Journal J Mol Model

Publisher Springer

Specialty Molecular Biology

Date 2012 Aug 9

PMID 22872415

Citations 5

Authors

Trevor Gokey

Teaster T Baird Jr

Anton B Guliaev

Affiliations

Soon will be listed here.

Abstract

Replacing the catalytic serine in trypsin with threonine (S195T variant) leads to a nearly complete loss of catalytic activity, which can be partially restored by eliminating the C42-C58 disulfide bond. The 0.69 μs of combined explicit solvent molecular dynamics (MD) simulations revealed continuous rearrangement of T195 with different conformational preferences between five trypsin variants tested. Among three conformational families observed for the T195 residue, one showed the T195 hydroxyl in a conformation analogous to that of the serine residue in wild-type trypsin, positioning the hydroxyl oxygen atom for attack on the carbonyl carbon of the peptide substrate. MD simulations demonstrated that this conformation was more populated for the C42A/C58V/S195T and C42A/C58A/S195T triple variants than for the catalytically inactive S195T variant and correlated with restored enzymatic activities for triple variants. In addition, observation of the increased motion of the S214-G219 segment in the S195T substituted variants suggested an existence of open and closed conformations for the substrate binding pocket. The closed conformation precludes access to the S1 binding site and could further reduce enzymatic activities for triple variants. Double variants with intact serine residues (C42A/C58A/S195 and C42A/C58V/S195) also showed interchange between closed and open conformations for the S214-G219 segment, but to a lesser extent than the triple variants. The increased conformational flexibility of the S1 subsite, which was not observed for the wild-type, correlated with reduced enzymatic activities and suggested a possible mode of substrate regulation for the trypsin variants tested.

Citing Articles

Dimerization misalignment in human glutamate-oxaloacetate transaminase variants is the primary factor for PLP release.

Lee J, Gokey T, Ting D, He Z, Guliaev A PLoS One. 2018; 13(9):e0203889.

PMID: 30208107 PMC: 6135512. DOI: 10.1371/journal.pone.0203889.

Engineering trypsin for inhibitor resistance.

Batt A, St Germain C, Gokey T, Guliaev A, Baird Jr T Protein Sci. 2015; 24(9):1463-74.

PMID: 26106067 PMC: 4570540. DOI: 10.1002/pro.2732.

Why Ser and not Thr brokers catalysis in the trypsin fold.

Pelc L, Chen Z, Gohara D, Vogt A, Pozzi N, Di Cera E Biochemistry. 2015; 54(7):1457-64.

PMID: 25664608 PMC: 4342846. DOI: 10.1021/acs.biochem.5b00014.

Protein dynamics via computational microscope.

Guliaev A, Cheng S, Hang B World J Methodol. 2014; 2(6):42-9.

PMID: 25237616 PMC: 4145563. DOI: 10.5662/wjm.v2.i6.42.

Evaluation of benzoic acid derivatives as sirtuin inhibitors.

Chen Y, Catbagan C, Bowler J, Gokey T, Goodwin N, Guliaev A Bioorg Med Chem Lett. 2013; 24(1):349-52.

PMID: 24269123 PMC: 3909564. DOI: 10.1016/j.bmcl.2013.11.004.

References

Shia S, Stamos J, Kirchhofer D, Fan B, Wu J, Corpuz R . Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B. J Mol Biol. 2005; 346(5):1335-49. DOI: 10.1016/j.jmb.2004.12.048. View

Puente X, Sanchez L, Gutierrez-Fernandez A, Velasco G, Lopez-Otin C . A genomic view of the complexity of mammalian proteolytic systems. Biochem Soc Trans. 2005; 33(Pt 2):331-4. DOI: 10.1042/BST0330331. View

Spraggon G, Hornsby M, Shipway A, Tully D, Bursulaya B, Danahay H . Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations. Protein Sci. 2009; 18(5):1081-94. PMC: 2771310. DOI: 10.1002/pro.118. View

McGrath M, VASQUEZ J, Craik C, Yang A, Honig B, Fletterick R . Perturbing the polar environment of Asp102 in trypsin: consequences of replacing conserved Ser214. Biochemistry. 1992; 31(12):3059-64. DOI: 10.1021/bi00127a005. View

Katz B, Finer-Moore J, Mortezaei R, Rich D, Stroud R . Episelection: novel Ki approximately nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface. Biochemistry. 1995; 34(26):8264-80. DOI: 10.1021/bi00026a008. View

Karplus M, McCammon J . Molecular dynamics simulations of biomolecules. Nat Struct Biol. 2002; 9(9):646-52. DOI: 10.1038/nsb0902-646. View

Bah A, Carrell C, Chen Z, Gandhi P, Di Cera E . Stabilization of the E* form turns thrombin into an anticoagulant. J Biol Chem. 2009; 284(30):20034-40. PMC: 2740429. DOI: 10.1074/jbc.M109.012344. View

Blanchard H, James M . A crystallographic re-investigation into the structure of Streptomyces griseus proteinase A reveals an acyl-enzyme intermediate. J Mol Biol. 1994; 241(4):574-87. DOI: 10.1006/jmbi.1994.1532. View

Frishman D, Argos P . Knowledge-based protein secondary structure assignment. Proteins. 1995; 23(4):566-79. DOI: 10.1002/prot.340230412. View

10.

Perona J, Tsu C, McGrath M, Craik C, Fletterick R . Relocating a negative charge in the binding pocket of trypsin. J Mol Biol. 1993; 230(3):934-49. DOI: 10.1006/jmbi.1993.1211. View

11.

Marquardt U, Zettl F, Huber R, Bode W, Sommerhoff C . The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region. J Mol Biol. 2002; 321(3):491-502. DOI: 10.1016/s0022-2836(02)00625-3. View

12.

Perona J, Craik C . Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. J Biol Chem. 1997; 272(48):29987-90. DOI: 10.1074/jbc.272.48.29987. View

13.

Case D, Cheatham 3rd T, Darden T, Gohlke H, Luo R, Merz Jr K . The Amber biomolecular simulation programs. J Comput Chem. 2005; 26(16):1668-88. PMC: 1989667. DOI: 10.1002/jcc.20290. View

14.

Guliaev A, Hang B, Singer B . Structural insights by molecular dynamics simulations into specificity of the major human AP endonuclease toward the benzene-derived DNA adduct, pBQ-C. Nucleic Acids Res. 2004; 32(9):2844-52. PMC: 419600. DOI: 10.1093/nar/gkh594. View

15.

Zakharova E, Horvath M, Goldenberg D . Structure of a serine protease poised to resynthesize a peptide bond. Proc Natl Acad Sci U S A. 2009; 106(27):11034-9. PMC: 2708782. DOI: 10.1073/pnas.0902463106. View

16.

Hedstrom L . Serine protease mechanism and specificity. Chem Rev. 2002; 102(12):4501-24. DOI: 10.1021/cr000033x. View

17.

Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

18.

Niu W, Chen Z, Gandhi P, Vogt A, Pozzi N, Pelc L . Crystallographic and kinetic evidence of allostery in a trypsin-like protease. Biochemistry. 2011; 50(29):6301-7. PMC: 3214630. DOI: 10.1021/bi200878c. View

19.

Neidhart D, Wei Y, Cassidy C, Lin J, Cleland W, Frey P . Correlation of low-barrier hydrogen bonding and oxyanion binding in transition state analogue complexes of chymotrypsin. Biochemistry. 2001; 40(8):2439-47. DOI: 10.1021/bi002535a. View

20.

Lee E, Hsin J, Sotomayor M, Comellas G, Schulten K . Discovery through the computational microscope. Structure. 2009; 17(10):1295-306. PMC: 2927212. DOI: 10.1016/j.str.2009.09.001. View